Stocks News

LAST PRICE
177.3950
TODAY'S CHANGE (%)
Trending Up0.4450 (0.2515%)

Bid / Lots
177.3800/ 7
Ask / Lots
177.4200/ 3
Open / Previous Close
177.0200 / 176.9500
Day Range
Low 176.7500
High 180.1900
52 Week Range
Low 137.6500
High 207.3200
Volume
3,773,854
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- AbbVie to Present at Citi's 2024 Global Healthcare Conference, from 5 hours ago by PR Newswire
  5 hours ago by PR Newswire
  Companies Mentioned: ABBV
  AbbVie (NYSE: ABBV) will participate in Citi's 2024 Global Healthcare Conference on Tuesday, December 3, 2024. Scott T. Reents, executive vice president, chief financial officer, Jeffrey R. Stewart, executive vice president, chief commercial officer and Roopal Thakkar, M.D., executive vice president, Research & Development and chief scientific officer, will present at 9:15 a.m. Central time.
- AbbVie to Present at Citi's 2024 Global Healthcare Conference, from 5 hours ago by Dow Jones
  5 hours ago by Dow Jones
  Companies Mentioned: ABBV
  
  AbbVie to Present at Citi's 2024 Global Healthcare Conference
  
  PR Newswire
  
  NORTH CHICAGO, Ill., Nov. 25, 2024
  
  NORTH CHICAGO, Ill., Nov. 25, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in Citi's 2024 Global Healthcare Conference on Tuesday, December 3, 2024. Scott T. Reents, executive vice president, chief financial officer, Jeffrey R. Stewart, executive vice president, chief commercial officer and Roopal Thakkar, M.D., executive vice president, Research & Development and chief scientific officer, will present at 9:15 a.m. Central time.
Nov 22, 2024
- AbbVie Shares Rise as Leerink Partners Upgrades Stock, from 3:08PM ET on Friday Nov 22, 2024 by MT Newswires
  3:08PM ET on Friday Nov 22, 2024 by MT Newswires
  Companies Mentioned: ABBV
  03:08 PM EST, 11/22/2024 (MT Newswires) -- AbbVie (ABBV) shares rose 3.1% in recent Friday trading as Leerink Partners upgraded the stock to outperform from market perform with a price target of $206. Intraday trading topped 6.49 million shares vers...
- DJ AbbVie Raised to Outperform From Market Perform by Leerink Partners, from 7:55AM ET on Friday Nov 22, 2024 by Dow Jones
  7:55AM ET on Friday Nov 22, 2024 by Dow Jones
  Companies Mentioned: ABBV
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/ABBV/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 22, 2024 07:55 ET (12:55 GMT)
- Leerink Partners Upgrades AbbVie to Outperform From Market Perform, Price Target is $206, from 6:34AM ET on Friday Nov 22, 2024 by MT Newswires
  6:34AM ET on Friday Nov 22, 2024 by MT Newswires
  Companies Mentioned: ABBV
  06:34 AM EST, 11/22/2024 (MT Newswires) -- AbbVie (ABBV) has an average rating of overweight and mean price target of $205.31, according to analysts polled by FactSet. (MT Newswires covers equity, commodity and economic research from major banks and...

Today
- DJ Roche Holding AG Falls Monday, from 1 hour ago by Dow Jones
  1 hour ago by Dow Jones
  Companies Mentioned: RHHBY
- DJ Novartis AG Falls Monday, Underperforms Market, from 1 hour ago by Dow Jones
  1 hour ago by Dow Jones
  Companies Mentioned: NVS
- DJ AstraZeneca PLC Stock Falls Monday, Underperforms Market, from 1 hour ago by Dow Jones
  1 hour ago by Dow Jones
  Companies Mentioned: AZN
- Jefferies Raises Merck Price Target to $150 From $149, Buy Rating Maintained, from 1 hour ago by MT Newswires
  1 hour ago by MT Newswires
  Companies Mentioned: MRK
- Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday Ahead of Key Inflation Data, from 5 hours ago by MT Newswires
  5 hours ago by MT Newswires
  Companies Mentioned: GLD, FAS, FAZ, IBB, IGM, IGV, SOXX, IVV, IWM, IYE, IYH, IYJ, IYK, IYW, BBWI, MRK, MS, QQQ, SPY, VDC, VHT, VIS, XLE, XLF, XLI, XLK, XLP, XLV, XLY, XSD, RTH, USO, SLV, XRT, EXI, RKLB, MOBX, BITO, UNG, EEM, EQT
- AstraZeneca PLC (AZN) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates, from 5 hours ago by Accesswire
  5 hours ago by Accesswire
  Companies Mentioned: AZN
- AstraZeneca PLC (AZN) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates, from 5 hours ago by Dow Jones
  5 hours ago by Dow Jones
  Companies Mentioned: AZN
- Astrazeneca Potential Metastatic Prostate Cancer Study Shows Early Promise, from 6 hours ago by MT Newswires
  6 hours ago by MT Newswires
  Companies Mentioned: AZN
- Merck Heart Disease Drug Meets Target in Phase 3 Study, from 6 hours ago by MT Newswires
  6 hours ago by MT Newswires
  Companies Mentioned: MRK
- TRUQAP(R) (capivasertib) combination in PTEN-deficient metastatic hormone-sensitive prostate cancer demonstrated statistically significant and clinically meaningful improvement in radiographic progression-free survival in CAPItello-281 Phase III trial, from 6 hours ago by Dow Jones
  6 hours ago by Dow Jones
  Companies Mentioned: AZN

AbbVie Inc
NYSE:ABBVUnited States

Search Criteria

Today

AbbVie to Present at Citi's 2024 Global Healthcare Conference, from 5 hours ago by PR Newswire

AbbVie to Present at Citi's 2024 Global Healthcare Conference, from 5 hours ago by Dow Jones

Nov 22, 2024

AbbVie Shares Rise as Leerink Partners Upgrades Stock, from 3:08PM ET on Friday Nov 22, 2024 by MT Newswires

DJ AbbVie Raised to Outperform From Market Perform by Leerink Partners, from 7:55AM ET on Friday Nov 22, 2024 by Dow Jones

Leerink Partners Upgrades AbbVie to Outperform From Market Perform, Price Target is $206, from 6:34AM ET on Friday Nov 22, 2024 by MT Newswires

Peers Headlines

Today

DJ Roche Holding AG Falls Monday, from 1 hour ago by Dow Jones

DJ Novartis AG Falls Monday, Underperforms Market, from 1 hour ago by Dow Jones

DJ AstraZeneca PLC Stock Falls Monday, Underperforms Market, from 1 hour ago by Dow Jones

Jefferies Raises Merck Price Target to $150 From $149, Buy Rating Maintained, from 1 hour ago by MT Newswires

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday Ahead of Key Inflation Data, from 5 hours ago by MT Newswires

AstraZeneca PLC (AZN) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates, from 5 hours ago by Accesswire

AstraZeneca PLC (AZN) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates, from 5 hours ago by Dow Jones

Astrazeneca Potential Metastatic Prostate Cancer Study Shows Early Promise, from 6 hours ago by MT Newswires

Merck Heart Disease Drug Meets Target in Phase 3 Study, from 6 hours ago by MT Newswires

TRUQAP(R) (capivasertib) combination in PTEN-deficient metastatic hormone-sensitive prostate cancer demonstrated statistically significant and clinically meaningful improvement in radiographic progression-free survival in CAPItello-281 Phase III trial, from 6 hours ago by Dow Jones